好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

An Open Labeled Observational Study of Rituximab and Plasma Exchange (PLEX) in Progressive Multiple Sclerosis (MS)
Multiple Sclerosis
(-)
264
Authors/Disclosures
Sara S. Qureshi, MD (Billings Clinic)
PRESENTER
No disclosure on file
Jaspreet Abraham (UT Southwestern.edu) No disclosure on file
No disclosure on file
Teresa Frohman, PA (Frohman & Frohman, PLLC) No disclosure on file
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Johannes Lorscheider The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Johannes Lorscheider has received research support from Innosuisse - Swiss Innvation Ageny. The institution of Johannes Lorscheider has received research support from MSBase Foundation. The institution of Johannes Lorscheider has received research support from Novartis.